S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
The Next Big Crisis Is Here (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Lots of sound and fury on US debt, but not a crisis — yet
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
The Next Big Crisis Is Here (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Lots of sound and fury on US debt, but not a crisis — yet
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
The Next Big Crisis Is Here (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Lots of sound and fury on US debt, but not a crisis — yet
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Is Buying an Aged Corporation a Good Idea?
MarketBeat Week in Review – 1/23- 1/27
The Next Big Crisis Is Here (Ad)
Visa, L3Harris rise; Intel, Eastman Chemical fall
How major US stock indexes fared Friday 1/27/2023
The Next Big Crisis Is Here (Ad)
Closing prices for crude oil, gold and other commodities
Lots of sound and fury on US debt, but not a crisis — yet
NASDAQ:NH

NantHealth - NH Stock Forecast, Price & News

$3.06
-0.07 (-2.24%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.06
▼
$3.20
50-Day Range
$0.19
▼
$5.70
52-Week Range
$1.57
▼
$15.75
Volume
3,615 shs
Average Volume
27,930 shs
Market Capitalization
$23.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NantHealth MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.43mentions of NantHealth in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.84 out of 5 stars

Medical Sector

816th out of 1,055 stocks

Data Processing & Preparation Industry

56th out of 72 stocks

See Top Rated MarketRank™ Stocks Here

NH stock logo

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Morrisville, NC.

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

January 28, 2023 | americanbankingnews.com
Head to Head Contrast: D-Wave Quantum (NYSE:QBTS) vs. NantHealth (NASDAQ:NH)
January 26, 2023 | americanbankingnews.com
NantHealth (NASDAQ:NH) Coverage Initiated at StockNews.com
January 28, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
January 16, 2023 | finance.yahoo.com
NantHealth, Inc. (NH) Stock Historical Prices & Data - Yahoo Finance
December 15, 2022 | finance.yahoo.com
NantHealth Announces 1-for-15 Reverse Stock Split
November 9, 2022 | finance.yahoo.com
NantHealth Third Quarter 2022 Earnings: US$0.12 loss per share (vs US$0.094 loss in 3Q 2021)
November 4, 2022 | finance.yahoo.com
NantHealth Reports 2022 Third Quarter Financial Results
November 1, 2022 | finance.yahoo.com
NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3
January 28, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
October 16, 2022 | fool.com
NantHealth, Inc. (NASDAQ: NH)
October 11, 2022 | finance.yahoo.com
WellStack Expands Executive Team with Chief Revenue Officer Christopher Rogowski - Yahoo Finance
October 5, 2022 | benzinga.com
11 Health Care Stocks Moving In Wednesday's Pre-Market Session - Applied DNA Sciences (NASDAQ:APDN), Aven - Benzinga
September 27, 2022 | globenewswire.com
Global Respiratory Care Devices Market expanding at a high-value CAGR of 8.3% by the end of 2032 - GlobeNewswire
September 9, 2022 | uk.investing.com
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday By Benzinga - Investing.com UK
September 5, 2022 | bizjournals.com
Billionaire's Morrisville firm tries to forestall stock delisting from the Nasdaq
August 24, 2022 | businesswire.com
NantHealth's Eviti Platform Once More Earns Full URAC Accreditation Through 2025 - Business Wire
August 24, 2022 | finance.yahoo.com
NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025
August 12, 2022 | finance.yahoo.com
Sarah Chavarria Named President of Delta Dental of California and Affiliates - Yahoo Finance
August 5, 2022 | fool.com
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript - The Motley Fool
August 5, 2022 | finance.yahoo.com
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript
August 4, 2022 | businesswire.com
NantHealth Reports 2022 Second Quarter Financial Results - Business Wire
August 4, 2022 | finance.yahoo.com
NantHealth Reports 2022 Second Quarter Financial Results
August 1, 2022 | finance.yahoo.com
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Yahoo Finance
August 1, 2022 | businesswire.com
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Business Wire
August 1, 2022 | finance.yahoo.com
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4
July 12, 2022 | streetinsider.com
Xealth Expands Leadership Team with Appointments of Joe Sedlak, RN, and Laurance Stuntz - StreetInsider.com
July 8, 2022 | finance.yahoo.com
NantHealth (NASDAQ:NH) investors are sitting on a loss of 90% if they invested five years ago
See More Headlines
Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings
11/03/2022
Today
1/28/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NH
Previous Symbol
NYSE:NH
CUSIP
N/A
CIK
1566469
Web
www.nanthealth.com
Phone
(310) 883-1300
Fax
N/A
Employees
326
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($7.6462)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-58,260,000.00
Net Margins
-89.76%
Pretax Margin
-89.67%
Return on Equity
N/A
Return on Assets
-30.69%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.36
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$62.65 million
Price / Sales
0.38
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($21.04) per share
Price / Book
-0.15

Miscellaneous

Outstanding Shares
7,710,000
Free Float
2,983,000
Market Cap
$23.59 million
Optionable
Optionable
Beta
1.96

Key Executives

  • Patrick Soon-ShiongPatrick Soon-Shiong
    Chairman & Chief Executive Officer
  • Ronald Allen LouksRonald Allen Louks
    Chief Operating Officer
  • Bob Petrou
    Chief Financial Officer
  • Tiffany Avery
    Chief Medical Officer
  • Brandon Villery
    Secretary, Senior VP-Legal, VP & General Counsel

Key Competitors

View All Competitors













NH Stock - Frequently Asked Questions

How have NH shares performed in 2023?

NantHealth's stock was trading at $3.65 at the beginning of 2023. Since then, NH shares have decreased by 16.2% and is now trading at $3.06.
View the best growth stocks for 2023 here.

Are investors shorting NantHealth?

NantHealth saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 56,200 shares, a decline of 29.1% from the December 31st total of 79,300 shares. Based on an average trading volume of 100,500 shares, the short-interest ratio is presently 0.6 days. Currently, 2.2% of the shares of the company are sold short.
View NantHealth's Short Interest.

When is NantHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our NH earnings forecast.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) announced its earnings results on Thursday, November, 3rd. The company reported ($0.13) EPS for the quarter. The firm had revenue of $16.63 million for the quarter.

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $3.06.

How much money does NantHealth make?

NantHealth (NASDAQ:NH) has a market capitalization of $23.59 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($7.6462) on an earnings per share basis.

How many employees does NantHealth have?

The company employs 326 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 1/28/2023 by MarketBeat.com Staff